HUTCHMED (China) Quote, Financials, Valuation and Earnings

HUTCHMED (China) Price Quote

+0.04 (+0.2%)
(Updated: January 27, 2023 at 6:50 PM ET)

HUTCHMED (China) Key Stats

HUTCHMED (China) (HCM) is a Buy

Day range:
$19.06 - $21.28
52-week range:
$7.39 - $28.40
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does HUTCHMED (China) Make?

Data Unavailable

Is HUTCHMED (China) Growing As A Company?

  • What Is HUTCHMED (China)'s Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.52%
  • What Is HUTCHMED (China)'s EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

HUTCHMED (China) Stock Price Performance

  • Did HUTCHMED (China) Stock Go Up Last Month?
    HUTCHMED (China) share price went up by 41.34% last month
  • Did HCM's Share Price Rise Over The Last Year?
    HCM share price fell by -25.59% over the past 1 year

What Is HUTCHMED (China) 52-Week High & Low?

HUTCHMED (China) Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy HUTCHMED (China)?

  • How Much Debt Does HUTCHMED (China) Have?
    Total long term debt quarterly is $418K
  • How Much Cash Does HUTCHMED (China) Have?
    Cash and short term investments quarterly total is $826.2M
  • What Is HUTCHMED (China)’s Book Value Per Share?
    Book value per share is 4.63

Is HUTCHMED (China) Cash Flow Positive?

Data Unavailable

HUTCHMED (China) Return On Invested Capital

  • Is Management Doing A Good Job?
    HCM return on invested capital is -35.3%
  • What Is HUTCHMED (China) Return On Assets?
    ROA measures how assets are converting to revenues and is -26.85%
  • What Is HCM Return On Equity?
    ROE is a measure of profitability and is -25.93%

HUTCHMED (China) Earnings Date & Stock Price

HUTCHMED (China) Competitors

  • Who Are HUTCHMED (China)'s Competitors?
    Below is a list of companies who compete with HUTCHMED (China) or are related in some way:
    • Global Cord Blood Corp (CO)
    • Magicstem Group Corp (MGGI)
    • Prenetics Global Ltd (PRE)
    • Regencell Bioscience Holdings Ltd (RGC)
    • Sino Biopharmaceutical Ltd (SBMFF)

HUTCHMED (China) Dividend Yield

Data Unavailable

HUTCHMED (China) Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -477.87%
Revenue: 51.52% -20.05%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 30.94
Upside from Last Price: 56.03%

Major Shareholders

  • How many HCM shares are owned by institutional investors?
    52.1M HCM shares are owned by institutional investors
  • How many HCM shares are owned by insiders?
    24.8M HCM shares are owned by insiders